This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Keio University, Tokyo Institute of Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 361 
1 out of 591 
Years Active: 2022
Title: Kentaro Suina: Innovator in Antitumor Agents
Introduction
Kentaro Suina is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His innovative approach has led to the creation of a unique formulation that holds promise in cancer treatment.
Latest Patents
Kentaro Suina holds a patent for an antitumor agent that includes water-soluble sulfasalazine as an active ingredient. This invention aims to provide an effective treatment option for cancer patients. The patent specifically describes a PEG-modified sulfasalazine, characterized by a formula where the average value of n is 4 or larger and 1136 or smaller.
Career Highlights
Throughout his career, Kentaro has worked with prestigious institutions such as Keio University and the Tokyo Institute of Technology. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kentaro has collaborated with notable colleagues, including Hideyuki Saya and Osamu Nagano. These partnerships have enhanced his research and development efforts, leading to advancements in antitumor therapies.
Conclusion
Kentaro Suina's innovative work in the development of antitumor agents showcases his dedication to improving cancer treatment. His contributions to the field are significant and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile